Could light therapy glasses help fight opioid cravings?

NCT ID NCT05459922

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This pilot study tested whether wearing bright light therapy glasses can improve sleep and reduce cravings in people being treated for opioid use disorder. Twenty-three adults on stable medication-assisted treatment (methadone or buprenorphine) with insomnia used either active or placebo light glasses for several weeks. The study focused on whether the treatment was feasible and acceptable, and looked for early signs of benefit on sleep, reward learning, and opioid craving.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Wearable bright light therapy device (Re-timer®)
What this could lead to
If it works, this could offer a simple, drug-free way to improve sleep and reduce opioid cravings for people in recovery.
What could go wrong
This is a very small pilot study (23 people) testing feasibility, not effectiveness. The results may not apply to everyone, and the placebo device looks identical, so blinding may be imperfect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSOMNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Arizona State University

    Phoenix, Arizona, 85004, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.